CMB International Capital Corporation is an investment banking firm based in Central, Hong Kong, that specializes in a wide array of financial services. Founded in 1987 as a subsidiary of China Merchants Bank, the firm offers comprehensive services including mergers and acquisitions, initial public offerings, equity underwriting, and corporate restructuring. It also provides project financing, business consulting, and various forms of debt financing. CMB International Capital serves a diverse clientele, comprising institutional, corporate, and individual clients both domestically and internationally. The firm is equipped to assist with share placements, refinancing for listed companies, and transaction advisory services, making it a versatile player in the financial services sector.
Dynanonic, established in 2007, is a Shenzhen-based company specializing in the research, development, production, and sales of nanomaterials, with a primary focus on nano-scale lithium-ion battery materials. The company operates multiple R&D and production facilities across China, including in Shenzhen, Foshan, Feicheng, and Pingshan.
Damo Intelligent Control
Series A in 2025
Damo Intelligent Control is a national specialized "little giant" enterprise and a national high-tech enterprise focusing on the research and development, production, sales, and service integration of drone cluster automation performance systems. It is the world's leading supplier of drone cluster automation performance systems.
Naen Auto
Venture Round in 2024
Shanghai NAEN Auto Technology Co., Ltd. specializes in automotive electronics, focusing on the development and manufacturing of advanced products for automobile manufacturers. The company's offerings include a range of systems such as passive entry passive start (PEPS), electronic steering column locks (ESCL), smart air conditioning (AC), body control modules (BCM), heads-up display (HUD) systems, domain control units (DCU), capacitive sensors (CS), and kick sensors (KS). By providing these innovative solutions, NAEN Auto supports the production of intelligent vehicles, enhancing functionality and user experience in modern automobiles.
Aiper
Series B in 2024
Pool cleaners of all types have been around as long as there have been pools; Aiper is the new kid on the block with a lot to prove. How would we make up the gap? By constantly innovating, throwing everything we have into R&D to raise the quality of your pool at every level. We do every test, have developed dozens of sensors and hundreds of algorithms, all ageared to making your pool experience the best, most effortless experience possible – that is the Aiper promise. With over one million dollars in crowdfunding, more than any other cordless robotic pool cleaning product, people are taking notice.
Tianchen Biotechnology
Series A in 2024
Tianchen Biotechnology is a biotechnology company focused on the development and sale of medical products for ophthalmology. It offers a range of solutions, including portable treatment equipment for patients and comprehensive diagnostic and treatment systems for medical institutions, aiming to enhance eye health.
Hengyu Biotechnology
Series B in 2024
Hengyu Biotechnology is a specialized provider of biological testing services aimed at drug developers. Founded by a scientific research team, the company focuses on delivering comprehensive biosafety testing solutions for innovative pharmaceutical companies worldwide. Its services include viral clearance process validation, cell bank validation, replicative virus testing, batch release testing, CGT bioanalysis, and process residue testing. These offerings are designed to meet regulatory filing requirements across the United States, China, and Europe, supporting the entire life cycle of biologics from research and development to marketing.
Yundao Zhizao
Series C in 2024
Yundao Zhizao develops the general multi-physics simulation PaaS platform and creates a controllable general simulation engine. They provide simdroids and engineering module development. They serve the petroleum and petrochemical industries, aerospace, automobiles, shipbuilding, weapons, nuclear energy, rail transit, and other key industries.
BIODEP
Venture Round in 2024
Biodep is a biotechnology company based in Wuxi, China, focused on the development and production of probiotics and their derivatives. These products are utilized across various industries, including food, healthy foods, cosmetics, environmental remediation, and contemporary agriculture. By leveraging biotechnology research and applications, Biodep aims to provide innovative solutions that enhance the quality and sustainability of these sectors.
Zhongke Hydroyi
Seed Round in 2023
Zhongke Hydroyi focuses on the research and development of polymer diaphragm products.
Alpha Better
Series A in 2023
Alpha Better specializes in compound semiconductor wafer-level inspection equipment. The company is dedicated to improving the yield control level of semiconductor material substrates, epitaxy, and chips through the use of optical detection methods. Yiben's foundation is material analysis and characterization technology, with photonic optics and artificial intelligence at its core, and it provides quantitative, standardized, and intelligent detection tools to help China's semiconductor industry break through the historical development process.
AutoCore
Series B in 2023
AutoCore is a provider of intelligent mobility software and solutions for automotive electrical and electronic architecture. The company focuses on developing an automotive middleware platform that supports next-generation vehicles, offering tailored operating systems and autonomous driving software for various EEA computing platforms. By assisting Original Equipment Manufacturers (OEMs) and Tier 1 suppliers throughout the entire life cycle, from design to production, AutoCore plays a critical role in advancing automotive technology and innovation.
KHAT
Series C in 2023
KHAT is a developer and producer of electronically controlled suspension for passenger vehicles.
Hongdao New Materials
Series A in 2023
Hongdao New Materials is a technology-based company that specializes in the research, development, production, and sale of solar module packaging film materials.
Red Sun Optoelectronics
Venture Round in 2023
Red Sun Optoelectronics is a state-owned high-tech enterprise specializing in photovoltaic equipment, intelligent manufacturing system integration applications, R&D, and production.
Neurophth Therapeutics
Series C in 2023
Wuhan Neurophth Biotechnology Co., Ltd. is a pioneering ophthalmology gene drug research and development company based in Wuhan, China, established in 2008. It focuses on gene therapies for ocular genetic diseases, with a particular emphasis on Leber hereditary optic neuropathy (LHON), a condition caused by genetic mutations. Neurophth has made significant advancements in the field, completing the world's first clinical study of gene therapy for LHON in 2011, which involved nine patients and has since observed their progress over seven years. The company aims to develop effective treatments for various ophthalmic disorders, including degenerative optic nerve injuries and vascular retinopathy, thereby providing physicians with innovative therapeutic options for patients suffering from these conditions.
Singsun
Series A in 2023
Singsun is a service provider focusing on providing advanced smart photovoltaic tracking support system solutions and intelligent manufacturing.
Continental hydrogen production
Venture Round in 2023
Continental involved in development, designing, manufacturing and management of hydrogen production equipment and gas purification equipment.
China Reserve National Energy
Series A in 2023
China Reserve National Energy is a developer of air energy storage technology. This technology has the advantages of large scale, low cost, long life, clean and pollution-free, unlimited energy storage period, independent of fossil fuels and geographical conditions, etc.
INTAMSYS
Series B in 2023
INTAMSYS Technology Co. Ltd. is a Shanghai-based company that specializes in the design and manufacture of 3D printers and additive manufacturing systems. The company focuses on high-performance functional materials, offering advanced 3D printing solutions tailored for various sectors, including aerospace, automotive, medical, engineering, oil and gas, and education. INTAMSYS's flagship products, the FUNMAT HT and FUNMAT PRO HT printers, are engineered for affordability and high performance, meeting the needs of functional materials 3D printing. In addition to manufacturing printers, INTAMSYS provides comprehensive additive manufacturing services, including the creation of functional prototypes, tooling, fixtures, and mass production of final products. All INTAMSYS printers adhere to strict quality standards and have received necessary certifications, ensuring reliability and performance in diverse industrial applications.
CyweeMotion
Series B in 2023
CyweeMotion specializes in perception fusion technology, focusing on the development of somatosensory solutions for consumer electronics. The company utilizes a nine-axis fusion sensor method to enhance the functionality of wearable devices, such as smartwatches and fitness trackers, by improving motion detection and health monitoring features. This technology enables more accurate real-time calibration of motion data, which enhances sports performance assessments while minimizing power consumption and reducing data transmission delays. CyweeMotion's innovations extend to applications in smart wear, earwear, the Internet of Things (IoT), and augmented/virtual reality (AR/VR), including advanced gesture recognition capabilities.
Obsbot
Series C in 2023
Obsbot uses revolutionary technology and innovative products to innovate the way public records are created and images are created and to change people's social ways. Its focus areas include visual intelligence based on deep learning, computer photography, and intelligent shooting technologies. It sells an artificial intelligence camera for recording and image creation.
Yinjia Biotechnology
Series A in 2023
Yinjia Biotechnology is a technology platform company devoted to source innovation and introduction, cooperation, and development, with an engagement in the widespread use of proteins in biomedicine and other major livelihood fields. The early stages of development, products, and services such as diagnosis, vaccines, key core raw materials for new drugs, and cell therapy.
Zhide New Energy
Series B in 2023
Zhide New Energy is a developer of approaches to synthetize new silicon anode materials. They focuses on silicon technology that can be applied to produce new materials. They also produce battery with high energy density and low cost. They manufactures battery for 3C and EV. They provide batteries for fields, such as electric vehicles, consumer electronics, house power storage, and wearable devices.
KM Soft
Venture Round in 2022
KM Soft software is used in equipment manufacturing enterprises such as aviation, aerospace, aviation development, shipbuilding, electronics, automobiles, and construction machinery. Their software product center includes digital platforms, digital research and development, digital process, digital manufacturing, and 3D tool software.
Microquanta
Series D in 2022
Microquanta, based in Hangzhou, specializes in the development and manufacturing of perovskite solar cell modules, which represent an innovative approach to solar technology. These modules are designed to deliver higher electricity conversion rates at lower costs compared to traditional solar technologies. The company's latest perovskite mini-module achieves an electricity conversion rate of 17%, surpassing its previous record of 16%. With a total funding of $10 million secured, Microquanta aims to further commercialize its technology and establish production lines within the year. By offering high energy conversion efficiency, the company provides flexible clean energy solutions to its business clients.
.bit
Series A in 2022
.bit provides a globally unique account system with the .bit suffix. The leading technical architecture of .bit allows both blockchain and non-blockchain users to use it without permission. .bit’s “cross-chain” feature is achieved in a way of cryptography-level security. As a DID system, .bit meets the ultimate requirements of Web3.0. .bit makes your asset transfer more convenient and secure. It can serve as the unified username in different Dapps. It can be used as a portal for Dapps. It provides you with a decentralized personal homepage (.bit.cc). It bridges the gap between Web2.0 and Web3.0. Discord:https://discord.gg/did Twitter:https://twitter.com/dotbitHQ Medium: https://dotbit.medium.com/ GitHub: https://github.com/dotbitHQ Forum:https://talk.did.id/
Comet Crystal New Materials
Series B in 2022
Comet New Materials provides thermal interface materials, electromagnetic shielding, and absorbing materials, die-casting alloy materials, and ceramic products.
Xita Technology
Series A in 2022
Hangzhou Xita Technology Co., Ltd. specializes in providing blockchain integrated solutions aimed at facilitating digital upgrades for various industries, including government entities, large state-owned enterprises, universities, and research institutions. Founded in 2019 and headquartered in Hangzhou, China, with additional branches in Beijing, Guangzhou, and Shanghai, the company offers a range of products to enhance business operations. Its offerings include RivSpace, a blockchain infrastructure product, RivTrust, which enables secure data element transfer, and CITA, an open-source underlying platform, along with CITA-Cloud, a development framework. These solutions are designed to help organizations efficiently build web 3.0 applications, improve customer acquisition, and increase operational efficiency.
ATAPEX
Series A in 2022
ATAPEX specializes in ultra-precision metal sheet processing, primarily targeting the production of precision metal masks essential for OLED panel manufacturing. The company offers a range of products including Divide Open Masks for AMOLED displays, Divide Fine Metal Masks, Micro OLED Open Masks for silicon-based OLEDs, and metal support sheets for display terminals. By addressing challenges such as limited product options, inconsistent quality, and lengthy delivery times, ATAPEX aims to enhance the efficiency of the display panel industry. Its commitment to large-scale mass production and high-quality localization positions the company as a key player in providing comprehensive solutions for customers in the OLED panel sector.
Basic Semiconductor
Series C in 2022
BASiC Semiconductor Ltd. is a China-based company founded in 2016 that focuses on the development and industrialization of silicon carbide (SiC) power devices. Operating within the wide-band gap semiconductor industry, BASiC Semiconductor is dedicated to research and development, with multiple R&D centers located in Shenzhen, Beijing, Nanjing, Wuxi, and Nagoya, Japan. The company boasts a highly skilled R&D team, which includes over ten PhD holders from prestigious institutions such as the University of Cambridge and Tsinghua University. BASiC Semiconductor offers a comprehensive range of services, including material preparation, chip design, manufacturing processes, packaging, and testing of advanced semiconductors. By doing so, it aims to enhance electrical performance and reduce costs for its clients in various sectors, including electronics and automotive industries.
Huashun Xin'an
Series C in 2022
Huashun Xin'an develops internet security systems for enterprise cybersecurity protection. It specializes in developing network security systems that focus on big data cyberspace mapping to provide effective cybersecurity solutions for enterprises and governments. The core technical capabilities of the company have been continuously improved through black production portraits, big data correlation and analysis, and research on offensive and defensive technologies, which can provide users with continuous and reliable cyberspace security construction and security services.
Rona Therapeutics
Series A in 2022
Rona Therapeutics is an RNA therapeutics platform focused on the discovery, development, and commercialization of innovative RNA medicines. The company specializes in modular and programmable RNA therapies, offering services that encompass oligonucleotide therapies, RNA editing, and polymeric molecules. Rona Therapeutics aims to create transformative RNA treatments that can significantly alter disease management across various therapeutic areas. To achieve this, the company is developing advanced facilities to enhance nucleic acid synthesis, delivery systems, oligonucleotide chemical modification, and RNA biology. By fostering an environment that promotes innovation, Rona Therapeutics is dedicated to improving patient outcomes and supporting healthier, longer lives.
METiS Pharmaceuticals
Series B in 2022
Jitai Medicine (METiS) is a biotechnology company that uses artificial intelligence to drive drug delivery and drug discovery. It combines advanced technologies like artificial intelligence, machine learning, and quantum simulation to achieve more effective design of innovative delivery materials, drug candidate selection and formulation design, "programmable nucleic acid drug" development, and nucleic acid delivery design.
METiS Therapeutics
Series B in 2022
METiS Therapeutics is a biotechnology company that aims to drive therapies in a wide range of disease areas by integrating drug discovery and delivery with AI, machine learning, and quantum simulation.
HemaCell
Seed Round in 2022
HemaCell is a cell therapy company specializing in the in vitro regeneration of hematopoietic lineages, including blood and immune cells. Founded by experts with extensive experience in the field, the company utilizes advanced stem cell reprogramming and differentiation technologies to develop innovative solutions. HemaCell is focused on addressing the pressing demand for platelets in the treatment of various conditions, such as cancer, liver disease, critical illnesses, and hematological disorders. Additionally, the company is dedicated to creating new therapeutic drugs targeting diseases associated with platelet abnormalities, thereby offering effective treatment options for patients.
Innoscience
Series D in 2022
Innoscience (Zhuhai) Technology Co Ltd. is a semiconductor company based in Zhuhai, China, founded in 2015. It specializes in the development and production of third-generation semiconductor power electronic devices, focusing primarily on gallium nitride (GaN) technology. As an integrated device manufacturer, Innoscience produces a range of GaN products, including discrete chips, integrated circuits, wafers, and modules. These products cater to various sectors, such as consumer electronics, renewable energy, industrial applications, automotive electronics, and data centers. The company's offerings are designed to provide high-frequency performance and low on-resistance, addressing the needs of modern power semiconductor applications.
ABclonal
Series D in 2021
ABclonal Inc. is a life science research and diagnostic reagents provider based in Woburn, Massachusetts, founded in 2016. The company specializes in offering a variety of biological research agents and services, including next generation sequencing library preparation kits, molecular biology products, catalog antibodies, catalog proteins, ELISA kits, and western blot tools and reagents. In addition to its extensive product range, ABclonal provides customized services related to peptides, antibodies, and proteins. The company distributes its products through a network of distributors across Europe, Asia, North America, and Oceania, aiming to enhance the quality of life science research with its high-quality offerings.
Jiahe Jinwei
Series B in 2021
Jiahe Jinwei has an industry-leading R&D team and several fully automated high-speed SMT production lines. Provide a full range of high-quality products and solutions such as memory modules, SSD solid state drives, various storage devices; at the same time, products are widely used in mobile terminals, personal computers, communication equipment, industrial control computer systems, enterprise-level servers, data centers, Cloud storage, etc.; also provide customers with special customized services to meet market differentiated and innovative needs. The company has set up factories and R&D centers in Shenzhen and Taiwan, and set up multiple laboratories for material testing, compatibility testing, reliability testing, and chip debugging experiments, covering an area of more than 8,000 square meters.
Neurophth Therapeutics
Series C in 2021
Wuhan Neurophth Biotechnology Co., Ltd. is a pioneering ophthalmology gene drug research and development company based in Wuhan, China, established in 2008. It focuses on gene therapies for ocular genetic diseases, with a particular emphasis on Leber hereditary optic neuropathy (LHON), a condition caused by genetic mutations. Neurophth has made significant advancements in the field, completing the world's first clinical study of gene therapy for LHON in 2011, which involved nine patients and has since observed their progress over seven years. The company aims to develop effective treatments for various ophthalmic disorders, including degenerative optic nerve injuries and vascular retinopathy, thereby providing physicians with innovative therapeutic options for patients suffering from these conditions.
Ultraleap
Series D in 2021
Ultraleap Limited is a leading developer of mid-air haptic control systems and 3D hand tracking technology. Formerly known as Ultrahaptics, the company specializes in creating solutions that utilize ultrasound to generate tactile sensations, enabling users to feel three-dimensional shapes and textures without physical contact. Its flagship products include the Leap Motion Controller, which captures hand movements, and the VR Developer Mount, designed for enhancing virtual reality experiences on various headsets. The company's innovative technology is applicable across multiple industries such as extended reality, automotive, digital signage, industrial automation, consumer electronics, and location-based entertainment. Established in 2013 and headquartered in Bristol, United Kingdom, Ultraleap also has a subsidiary in Silicon Valley, United States.
Hypersics Semiconductor
Series A in 2021
Hypersics Semiconductor Co Ltd is a prominent semiconductor company based in Yizheng, China, specializing in the research, development, and industrialization of 6-inch silicon carbide substrates. The company focuses on integrating innovative overseas technologies with domestic resources to enhance its capabilities. It has established a strong research and development team by attracting both overseas returnees and foreign experts, thereby fostering a high level of expertise within the organization. Hypersics Semiconductor aims to lead advancements in the semiconductor industry, particularly in the growing field of silicon carbide technologies.
Huasun Energy
Series A in 2021
Huasun Energy, founded in 2020 and based in Hefei, China, focuses on the production and sales of high-efficiency silicon heterojunction solar cells and components. The company specializes in heterojunction technology and is dedicated to research and development in this field. By promoting the use of solar energy, Huasun Energy plays a significant role in advancing the green energy industry, contributing to a more sustainable future through its innovative solar solutions.
SJ Semi
Series C in 2021
SJ Semi is a MEOL foundry focused on front-end wafer manufacturing and quality systems. The company specializes in bumping, Cu pillar, RDL, and testing services for 12" wafers while investing in R&D for fan-out, TSV, interposer, and 3D technologies. With over a decade of experience, SJ Semi aims to support advancements in the semiconductor market.
Amador Bioscience
Series B in 2021
Amador Bioscience is a contract research organization that specializes in providing translational sciences and clinical pharmacology services to biopharmaceutical companies. Their core offerings include bioanalysis and biomarker services, which support drug development by measuring drug concentrations and identifying biomarkers relevant to specific diseases or therapies. Additionally, they provide clinical research services, assisting clients with the design, conduct, and analysis of clinical trials. Amador Bioscience also offers consulting services in areas such as clinical pharmacology, medicine validation, and regulatory submission, helping pharmaceutical companies navigate the complexities of drug development and approval processes.
Sineva
Private Equity Round in 2021
Hefei Sineva Intelligent Machine Co., Ltd., established in 2013 and located in Hefei, China, specializes in the research, development, manufacturing, and sales of transfer, test, and service robots. The company operates under the umbrella of Zhejiang Qianjiang Biochemical Co., Ltd. Sineva focuses on providing AI-based machine vision solutions and advanced materials that cater to semiconductor production and drug development. Its business encompasses four main areas: intelligent manufacturing machinery, advanced materials, artificial intelligence, and aircraft. By addressing critical technical gaps in the domestic pan-semiconductor industrial robot sector, Sineva positions itself as a key player in the evolving landscape of intelligent manufacturing.
XINYI Information Technology
Series B in 2021
XINYI Information Technology Ltd specializes in the design, development, and sale of system integration and Internet of Things (IoT) communication chips, particularly for the radio frequency simulation industry. The company offers products such as the XY1100 CMOS chip and also provides technical consulting and electronic product development services. Founded in 2017, XINYI is headquartered in Shanghai, China, with additional offices in Shenzhen and Nanjing, as well as a presence in Silicon Valley, California. The company boasts extensive research and development capabilities with centers located in Shanghai, Nanjing, Chengdu, and Singapore, along with sales offices in Xi'an, Chongqing, and Shenzhen, and a supply chain center in Hong Kong. The founding team consists of professionals with experience from leading communication chip firms, including Broadcom, Qualcomm, and Intel, and includes graduates from prestigious universities both domestically and internationally.
Jyss Bio
Series B in 2021
Jyss Bio is a developer of disposable bioreactors and peripheral equipment.
Thoth Medical
Series C in 2021
Thoth Medical specializes in the development of medical wearables that incorporate advanced biomedical sensor technology. The company focuses on integrating various technologies, including wireless transmission, artificial intelligence algorithms, and cloud monitoring, to create devices that enhance clinical medical services. Thoth Medical aims to deliver precise, efficient, comfortable, and safe solutions for healthcare, ultimately improving patient care through innovative wearable technology.
Ultipa
Series A in 2021
Ultipa is a tech company specializing in advanced graph database solutions, founded by experienced entrepreneurs from Silicon Valley. It has developed a fourth-generation graph database system aimed at enhancing enterprise digital transformation through speed, flexibility, and clarity. Ultipa's product offerings include the Ultipa Graph database, Ultipa Manager, and various applications tailored for sectors such as risk management, asset-liability management, and liquidity management. The company is focused on helping businesses extract maximum value from complex data sets, moving beyond traditional relational databases and big-data frameworks. Ultipa also offers a cloud-based version of its graph database, released in November 2022, which operates as a Database-as-a-Service (DBaaS) and Software-as-a-Service (SaaS) solution. The company serves a diverse clientele, including major banks, stock exchanges, and large enterprises, aiming to address customer challenges while ensuring lower total cost of ownership and higher returns on investment.
Clustar
Series A in 2021
Clustar is an artificial intelligence computing platform service provider. Bohai Nebula applies super-calculated research and technical results to the commercial field, providing an efficient distributed machine learning system for enterprise AI. At present, Xingyun Clustar is a project-based way to help companies land, with a unit price of one million yuan. For some enterprises with weak information and intelligence, Xingyun also provides integrated software and hardware solutions, including Ethernet RDMA + intelligent network card / self-developed switch
Abiochem Biotechnology
Series C in 2021
Abiochem Biotechnology is a high-tech enterprise specializing in enzyme engineering and genetic engineering technologies. The company focuses on researching and developing biocatalytic and synthetic biology methods, which are applied to large-scale production across various sectors. Its innovations are utilized in pharmaceuticals, health care products, and pesticides, contributing to advancements in green chemistry. Abiochem Biotechnology offers customized genetic and enzyme engineering services, positioning itself as a provider of bio-intelligent manufacturing solutions for chemical and biological products.
PackGene Biotech
Series C in 2021
PackGene Biotech, LLC is a biotechnology company based in the United States that specializes in developing viral vectors for gene therapies. It primarily focuses on adeno-associated virus (AAV) vectors, offering comprehensive services that include vector design, cloning, and packaging. The company also provides solutions for mRNA, plasmid DNA, and lentiviral vectors. With an emphasis on early-stage drug discovery and preclinical development, PackGene Biotech supports researchers in the medical industry by delivering high-purity, high-titer, and high-infectivity vectors for clinical applications. Its capabilities enable scalable and cost-effective production, facilitating advancements in cell and gene therapy trials.
Qihan Biotech
Series A in 2021
Qihan Biotech is a biomedical company specializing in genetic technology with a focus on xenotransplantation. The company aims to address the critical shortage of organ donors by utilizing advanced gene editing techniques to develop safe and effective cells, tissues, and organs for human transplantation. Their mission is to eliminate the waiting period associated with organ transplants, providing patients with access to life-saving organs. By harnessing cutting-edge genetic editing technology, Qihan Biotech seeks to create viable organs that can be transplanted into humans, thereby contributing to a solution for the global organ donor crisis.
YuanHua Zhineng
Series A in 2021
YuanHua Zhineng specializes in sophisticated medical and intelligent service robots. The company provides a robot system for orthopedic surgery that can help surgeons with a variety of procedures, including spine, knee/hip replacement, trauma, and knee/hip replacement.
EpimAb Biotherapeutics
Series C in 2021
EpimAb Biotherapeutics is a biopharmaceutical company based in Shanghai, China, focused on the research and development of novel bispecific antibody therapeutics. Utilizing its proprietary Fabs-In-Tandem Immunoglobulin (FIT-Ig) platform, the company creates bispecific molecules that possess antibody-like properties. This innovative approach aims to address the challenges associated with developing effective bi-specific antibodies, which are engineered from two different monoclonal antibodies to combine their therapeutic features into a single entity. These bispecific antibodies hold promise for treating various life-threatening conditions, particularly in immuno-oncology, by offering new therapeutic options. Despite the potential benefits of bi-specific antibodies, many candidates face hurdles in development due to issues related to their binding properties, pharmacokinetics, and production costs. EpimAb Biotherapeutics is positioned to contribute to the growing need for advanced bi-specific therapeutics in the pharmaceutical industry.
Guoquan Shihui
Series D in 2021
Guoquan Shihui is a prominent food supplier in China specializing in hot pot and barbecue products. The company operates a supermarket convenience store chain that offers a wide range of food items, including casual snacks, fresh ingredients, and prepared meals. Guoquan Shihui employs both B2B and B2C models, combining offline retail with an online presence to meet the needs of small and medium-sized catering businesses and provide convenient meal solutions for consumers. The brand focuses on enhancing home dining experiences by offering ready-to-eat, ready-to-heat, and ready-to-cook products, enabling families to enjoy tasty meals with ease. With an extensive network of nearly 10,000 retail locations, Guoquan Shihui is committed to delivering quality and convenience across diverse dining scenarios.
Newlink
Series E in 2021
Newlink primarily operates as a digital energy service provider. It promotes energy change, the energy Internet of Things EIoT, and an energy new retail platform. It is a dual-material unicorn at home and abroad, one of the world's top 500 new energy companies, with more than 3,000 employees. Covering oil, electricity, hydrogen, and gas multiple energy categories, opening up the upstream and downstream of the energy industry chain, and digitally reconstructing the energy ecology.
CotheraBio
Venture Round in 2021
CotheraBio develops innovative cancer therapies with a focus on translational oncology. It has developed its proprietary i-CR® technology platform, which is a powerful method for providing individualized drug screening and new drug development. The platform combines a high content screening system with the conditional reprogramming of primary cultured tumor cells, which enables the efficient and undifferentiated expansion of primary patient-derived tumor cells in vitro, while also preserving the tumor’s heterogeneity.
Innoscience
Series C in 2021
Innoscience (Zhuhai) Technology Co Ltd. is a semiconductor company based in Zhuhai, China, founded in 2015. It specializes in the development and production of third-generation semiconductor power electronic devices, focusing primarily on gallium nitride (GaN) technology. As an integrated device manufacturer, Innoscience produces a range of GaN products, including discrete chips, integrated circuits, wafers, and modules. These products cater to various sectors, such as consumer electronics, renewable energy, industrial applications, automotive electronics, and data centers. The company's offerings are designed to provide high-frequency performance and low on-resistance, addressing the needs of modern power semiconductor applications.
Codemao
Series D in 2020
Codemao is an online education platform focused on teaching children computer coding through an engaging and interactive approach. Founded in 2015 by Tianchi Li and Yue Sun in Shenzhen, Guangdong, the platform utilizes a proprietary visual programming tool that allows students to create games, software, animations, and stories. By incorporating gamification into its curriculum, Codemao aims to make learning programming enjoyable and effective, catering to the unique learning characteristics of children. The platform not only emphasizes programming skills but also fosters logical thinking, creativity, and teamwork among young learners. Through its dynamic online community and game-based courses, Codemao provides a comprehensive educational experience that combines digital knowledge with various disciplines.
SmartSens Technology
Series B in 2020
SmartSens Technology is a company based in Shanghai that specializes in the research, development, design, and sales of high-performance CMOS image sensor chips. The company offers advanced imaging solutions applicable in various sectors, including surveillance, machine vision, automotive, and mobile cameras. With a commitment to innovation, SmartSens aims to enhance growth across multiple industries by providing a diverse and comprehensive portfolio of image sensors.
Dingdang Kuaiyao
Series B in 2020
Dingdang Kuaiyao is an online-to-offline drug purchasing and delivery platform. After users place orders on the mobile app, drugs will be delivered to their homes within half an hour.
InventisBio
Series D in 2020
InventisBio Inc. is a biotechnology company focused on discovering and developing innovative therapeutics for cancer and metabolic diseases. Founded in 2013 and based in Pudong, China, the company specializes in targeted therapies, particularly for lung cancer, breast cancer, and gout. Its product pipeline includes small molecule drug candidates, such as D-0316, a third-generation EGFR-T790M tyrosine kinase inhibitor. InventisBio is also engaged in developing novel immuno-oncology therapies that can be used in conjunction with existing treatments like PD-1 antibodies for various cancer types. The company was co-founded by Dr. Yaolin Wang and other scientists with extensive experience in drug discovery at leading pharmaceutical firms, focusing on significant health challenges such as tumors and metabolic disorders.
Biocytogen
Series D in 2020
Biocytogen LLC is a biotechnology company based in Worcester, Massachusetts, that specializes in developing gene-targeted animal models for life science research. Founded in 2008, the company offers a range of services, including customized and off-the-shelf mouse models, phenotype analysis, and advanced gene-editing techniques. Its products encompass various types of mice, such as knockin and knockout models, as well as humanized mice, catering to diverse research areas including immunology, neurology, cancer, and infectious diseases. Biocytogen also operates a state-of-the-art animal facility to support its integrated platform for efficient antibody drug discovery and validation. The company collaborates with leading pharmaceutical and biotechnology firms to enhance preclinical research and development processes in the biomedical field.
Haihe Biopharma
Series B in 2020
Haihe Biopharma is dedicated to the discovery, development, and commercialization of innovative anti-tumor drugs aimed at addressing complex diseases. The company specializes in pharmacological efficacy evaluation and offers a range of products, including novel topoisomerase I inhibitors and highly selective oral c-Met inhibitors. By focusing on these advancements, Haihe Biopharma seeks to enhance health outcomes for patients and improve the quality of research in the pharmaceutical field.
BYD Semiconductor
Series A in 2020
BYD Semiconductor is an electronic components manufacturing company that specializes in the research and development of power semiconductors and integrated device manufacturing solutions. The company produces a range of products, including battery management chips, power field effect transistors, image sensors, touch control chips, protection diodes, and current sensors. BYD Semiconductor's offerings encompass semiconductor manufacturing and services that facilitate the sensing, processing, and control of optical, electrical, and magnetic signals. Its solutions cater to diverse industries such as automotive, energy, industrial, and consumer electronics.
Codemao
Series C in 2020
Codemao is an online education platform focused on teaching children computer coding through an engaging and interactive approach. Founded in 2015 by Tianchi Li and Yue Sun in Shenzhen, Guangdong, the platform utilizes a proprietary visual programming tool that allows students to create games, software, animations, and stories. By incorporating gamification into its curriculum, Codemao aims to make learning programming enjoyable and effective, catering to the unique learning characteristics of children. The platform not only emphasizes programming skills but also fosters logical thinking, creativity, and teamwork among young learners. Through its dynamic online community and game-based courses, Codemao provides a comprehensive educational experience that combines digital knowledge with various disciplines.
dForce
Seed Round in 2020
dForce Network is a company that develops and operates a decentralized finance (DeFi) application, founded in 2019 and based in China. It offers an integrated platform that includes various protocols such as stablecoin, liquidity, lending, and derivatives, enabling users to access a range of financial services without relying on traditional banking institutions or third parties. By leveraging blockchain technology, dForce aims to create an interconnected ecosystem of open finance protocols, catering to both individuals and enterprises. This focus on decentralization facilitates a broader access to financial services while promoting interoperability among different financial applications.
GIFT ADVISOR
Funding Round in 2020
GIFT ADVISOR is a gift selection tool with big data and artificial intelligence technology.
ArchForce Technology
Series B in 2020
ArchForce Technology, established in 2016, is a Shenzhen-based company that specializes in designing, developing, and providing core business systems and platforms for the securities and financial industry. Its product suite includes a message interconnection platform, trading platform, risk control system, and a trading highway, catering to the needs of various financial institutions such as securities firms, funds, banks, and insurance companies. The company's offerings span transactions, time clearing, risk management, speed markets, investment management, and wealth management marketing services, aiming to enhance the efficiency and capabilities of China's financial infrastructure.
North Ocean Photonics
Series B in 2020
North Ocean Photonics is a high-tech enterprise focusing on the field of micro-optics and optical integration.
Zhangshang Tangyi
Series D in 2020
Zhangshang Tangyi is a health management platform with a focus on diabetes. It allows patients to upload their own health data to their mobile app and receive treatment guidance from doctors. Zhangshang Tangyi was founded in 2014 and is based in Hangzhou, Zhejiang.
Huaqin Technology
Series B in 2019
Huaqin Technology Co Ltd is a leading player in the global smartphone and tablet original design manufacturing (ODM) industry. The company specializes in the research, development, design, and production of a wide range of intelligent hardware products, including smartphones, tablets, notebooks, servers, and IoT devices. As a partner of Google, Huaqin facilitates the creation of Android devices certified for security and functionality by Google Mobile Services. The company serves a diverse clientele across more than 100 countries and regions, focusing on delivering competitive and innovative products. By 2015, Huaqin had shipped over 200 million mobile phones and more than 5 million tablets annually, with a commitment to providing advanced 4G products. Guided by principles of integrity, diligence, focus, and innovation, Huaqin aims to enhance its product offerings and contribute to sustainable development in the technology sector.
Ultipa
Angel Round in 2019
Ultipa is a tech company specializing in advanced graph database solutions, founded by experienced entrepreneurs from Silicon Valley. It has developed a fourth-generation graph database system aimed at enhancing enterprise digital transformation through speed, flexibility, and clarity. Ultipa's product offerings include the Ultipa Graph database, Ultipa Manager, and various applications tailored for sectors such as risk management, asset-liability management, and liquidity management. The company is focused on helping businesses extract maximum value from complex data sets, moving beyond traditional relational databases and big-data frameworks. Ultipa also offers a cloud-based version of its graph database, released in November 2022, which operates as a Database-as-a-Service (DBaaS) and Software-as-a-Service (SaaS) solution. The company serves a diverse clientele, including major banks, stock exchanges, and large enterprises, aiming to address customer challenges while ensuring lower total cost of ownership and higher returns on investment.
Allystar Technology
Series A in 2019
Allystar Technology (Shenzhen) Co. Ltd. specializes in the design and development of satellite navigation chipsets and application solutions. Established in May 2013, the company became independent from the GNSS chipsets designing department in December 2016. It operates as a joint venture with investments from China Electronics Corporation and other prominent groups, with a registered capital of 400 million RMB. Headquartered in Shenzhen, Allystar focuses on research, development, and sales of navigation and positioning chips, as well as algorithms and products. Its offerings cater to various sectors, including consumer electronics, national vital industries, the automotive industry, and the Internet of Things (IoT). The company is recognized as a key player in enhancing the satellite navigation chip industry and is supported by the People's Government of Shenzhen Municipality.
iQuantex
Series A in 2019
iQuantex is a fintech company headquartered in Beijing, China, specializing in the development of an intelligent asset custodian and management platform. Founded in 2013, the company focuses on enhancing the investment management life cycle by offering comprehensive tools that cover various aspects, including investment product development, due diligence, execution, risk management, and post-deal analysis. The platform is designed to provide data-driven insights and integrated analytical tools, enabling money managers to increase both flexibility and efficiency in their investment processes.
Qihan Biotech
Series A in 2019
Qihan Biotech is a biomedical company specializing in genetic technology with a focus on xenotransplantation. The company aims to address the critical shortage of organ donors by utilizing advanced gene editing techniques to develop safe and effective cells, tissues, and organs for human transplantation. Their mission is to eliminate the waiting period associated with organ transplants, providing patients with access to life-saving organs. By harnessing cutting-edge genetic editing technology, Qihan Biotech seeks to create viable organs that can be transplanted into humans, thereby contributing to a solution for the global organ donor crisis.
Biocytogen
Series D in 2019
Biocytogen LLC is a biotechnology company based in Worcester, Massachusetts, that specializes in developing gene-targeted animal models for life science research. Founded in 2008, the company offers a range of services, including customized and off-the-shelf mouse models, phenotype analysis, and advanced gene-editing techniques. Its products encompass various types of mice, such as knockin and knockout models, as well as humanized mice, catering to diverse research areas including immunology, neurology, cancer, and infectious diseases. Biocytogen also operates a state-of-the-art animal facility to support its integrated platform for efficient antibody drug discovery and validation. The company collaborates with leading pharmaceutical and biotechnology firms to enhance preclinical research and development processes in the biomedical field.
Robosen
Series A in 2019
Robosen (Shenzhen) Co., Ltd., founded in 2008 and headquartered in Beijing, China, specializes in the development and manufacturing of intelligent robotics. The company offers a variety of products, including educational robots, vending robots, and smart fighting robots, aimed at enhancing convenience in daily life. One of its notable innovations, the "Pathfinder Pioneer," features the ability to store up to 1 million action programs and can transform between a human and a jeep shape. This product also supports mobile app control and visual 3D programming via a PC. Robosen's technology encompasses advanced features such as digital electric transmission, servo motors, artificial joints, and body language recognition, positioning the company as a key player in the consumer robotics market.
Tencent Trusted Doctors
Series C in 2019
Tencent Trusted Doctors, a company established in early August 2018 upon the merger of Tencent Doctorwork and Trusted Doctors, is acquiring the start-up in an attempt to create a private healthcare network that provides both online and offline services through the so-called "celebrity effect".
InventisBio
Series C in 2019
InventisBio Inc. is a biotechnology company focused on discovering and developing innovative therapeutics for cancer and metabolic diseases. Founded in 2013 and based in Pudong, China, the company specializes in targeted therapies, particularly for lung cancer, breast cancer, and gout. Its product pipeline includes small molecule drug candidates, such as D-0316, a third-generation EGFR-T790M tyrosine kinase inhibitor. InventisBio is also engaged in developing novel immuno-oncology therapies that can be used in conjunction with existing treatments like PD-1 antibodies for various cancer types. The company was co-founded by Dr. Yaolin Wang and other scientists with extensive experience in drug discovery at leading pharmaceutical firms, focusing on significant health challenges such as tumors and metabolic disorders.
Burning Rock
Series C in 2019
Burning Rock Biotech Limited specializes in developing and providing cancer therapy selection tests in the People's Republic of China. The company offers a range of next-generation sequencing-based tests applicable to various cancer types, including lung, gastrointestinal, prostate, breast, and others, using tissue and liquid biopsy samples. Its key products include OncoScreen Plus for therapy and immunotherapy guidance, LungPlasma for non-small cell lung cancer, ColonCore for gastrointestinal cancers, and HRDCore for homologous recombination deficiency testing. Burning Rock collaborates with major pharmaceutical companies like AstraZeneca and BeiGene for clinical trials and research studies, primarily through central laboratory and companion diagnostics services. Founded in 2014, the company is headquartered in Guangzhou, with a focus on providing individualized cancer treatment guidance using NGS and biomedical informatics.
Apollomics
Series B in 2019
Apollomics, Inc. is an emerging life sciences company based in Foster City, California, focused on developing innovative oncology therapies aimed at targeting the growth and proliferation of cancer cells. Founded in 2016, the company’s pipeline includes several development-stage assets, such as CBT-101, an oral agent that targets the epithelial to mesenchymal transition pathway associated with various tumors, and CBT-102, which inhibits the MAP Kinase pathway and angiogenesis through its effects on specific receptors. Additionally, Apollomics is advancing monoclonal antibodies CBT-501 and CBT-502, which target the PD-1 and PDL-1 membrane receptors, respectively, to enhance the immune response against cancer. By combining immune-based strategies with targeted therapies, Apollomics aims to develop novel treatments that can effectively combat cancer.
Bellen
Series C in 2018
Bellen Chemistry is a premier provider of a variety of heterocycles. Our activity is focused on the design and development of novel molecules,6361413375267061158256368.jpgintermediates for the Chemical and Pharmaceutical industries. Bellen Chemistryhas a strong R&D team with a talent pool of 200+ trained scientists. We have excellent track records, as we deliver unrivalled chemical innovation to our customers worldwide.
Tianrang
Series A in 2018
Tianrang, established in June 2016 and headquartered in Shanghai, specializes in developing comprehensive artificial intelligence solutions for various industries, including urban operation, traffic management, finance, and commercial retail. The company aims to create a universal AI platform that empowers enterprises, government agencies, and individuals to build proprietary AI engines designed to address everyday challenges. Utilizing technologies such as deep learning and machine learning, Tianrang has introduced several intelligent optimization products for online marketing, significantly improving marketing effectiveness for merchants. Their AI technology has also enhanced urban traffic management by optimizing traffic signals to improve overall city transit efficiency. Additionally, Tianrang has advanced in the field of Go, providing training and education that surpasses world championship levels. The founding team comprises alumni from prestigious universities and seasoned professionals from leading tech companies, bringing extensive expertise in machine learning and AI research. With branches in Hangzhou and Guangzhou, Tianrang is committed to promoting the growth of AI technology in China.
CMC
Series A in 2018
CMC Inc. is a Chinese state-backed media and entertainment conglomerate that produces a diverse array of content, including film, television dramas, financial media, music, and sports. Established in 2010, CMC Capital operates as a private equity and venture capital firm located in Shanghai, focusing on investments across various sectors such as culture, technology, media, entertainment, consumer goods, medical treatment, and telecommunications. The company's multifaceted approach enables it to influence multiple aspects of the media landscape while supporting growth in complementary industries.
Cambricon Technologies
Series B in 2018
Cambricon Technologies is a leading company in the development of artificial intelligence core chips, focusing on applications in cloud servers, edge computing devices, and terminal equipment. Founded by Professor Chen Tianshi, a recognized expert in processor architecture and artificial intelligence, the company has established itself as a pioneer in smart chip technology. It offers a diverse range of chip products and system software solutions, serving various industries including smart terminals and intelligent robotics. Notably, Cambricon introduced the Cambrian-1A processor in 2016, which was the first commercial deep learning processor designed for smartphones, wearable devices, and other terminal applications. The company continues to innovate in the field of AI chip technology, contributing to advancements in intelligent systems.
OncXerna Therapeutics
Seed Round in 2018
OncXerna Therapeutics, Inc. is a biotechnology company focused on developing precision medicines for cancer patients by utilizing an RNA-based biomarker platform. The company aims to improve patient outcomes by prospectively identifying individuals based on the unique RNA biology of their tumor microenvironments. This innovative approach enables OncXerna to match patients with targeted oncology therapies that correspond to their specific tumor characteristics. Founded in 2018 and based in Waltham, Massachusetts, with an additional location in Shanghai, China, OncXerna was formerly known as Oncologie, Inc. and changed its name in September 2020 to reflect its commitment to advancing next-generation precision medicine for a broader range of cancer patients.
Codemao
Series C in 2018
Codemao is an online education platform focused on teaching children computer coding through an engaging and interactive approach. Founded in 2015 by Tianchi Li and Yue Sun in Shenzhen, Guangdong, the platform utilizes a proprietary visual programming tool that allows students to create games, software, animations, and stories. By incorporating gamification into its curriculum, Codemao aims to make learning programming enjoyable and effective, catering to the unique learning characteristics of children. The platform not only emphasizes programming skills but also fosters logical thinking, creativity, and teamwork among young learners. Through its dynamic online community and game-based courses, Codemao provides a comprehensive educational experience that combines digital knowledge with various disciplines.
Lvkon.com
Series B in 2018
Suzhou Lvkon Transmission Technology Co., Ltd., established in 2011 and headquartered in Suzhou, China, specializes in the research, development, production, and sales of automotive technology. The company focuses on automatic transmission systems for vehicles, drive motors for new energy vehicles, and powertrains for both pure electric and hybrid vehicles. Lvkon.com is dedicated to enhancing energy efficiency, comfort, and overall performance in the new energy vehicle sector through its advanced technological capabilities and product development. The firm excels in critical areas such as new energy vehicle control, power system integration, and the design and manufacturing of essential components like transmissions and motors, positioning itself as a key player in the high-tech automotive market.
Roadstar.AI
Series A in 2018
Roadstar.AI is a startup based in Silicon Valley and Shenzhen, founded by experts in robotics and machine learning with backgrounds from prominent tech companies. The company specializes in autonomous driving technology aimed at enhancing transportation systems. Its innovative approach leverages a multi-sensor fusion framework that ensures precise time and spatial synchronization, enabling real-time updates and robust data extraction. By integrating artificial intelligence into vehicles, Roadstar.AI aspires to create safer, more efficient, and enjoyable travel experiences for all users.
Biocytogen
Series C in 2018
Biocytogen LLC is a biotechnology company based in Worcester, Massachusetts, that specializes in developing gene-targeted animal models for life science research. Founded in 2008, the company offers a range of services, including customized and off-the-shelf mouse models, phenotype analysis, and advanced gene-editing techniques. Its products encompass various types of mice, such as knockin and knockout models, as well as humanized mice, catering to diverse research areas including immunology, neurology, cancer, and infectious diseases. Biocytogen also operates a state-of-the-art animal facility to support its integrated platform for efficient antibody drug discovery and validation. The company collaborates with leading pharmaceutical and biotechnology firms to enhance preclinical research and development processes in the biomedical field.
Eucure Biopharma
Series B in 2018
Eucure Biopharma, established in 2016 and headquartered in Beijing, China, is a biotechnology company focused on the discovery and development of innovative immuno-oncology targeted antibodies. Its pipeline comprises eight drug candidates, primarily targeting immune checkpoints, with several in the clinical trial application stage. The company offers services such as antibody production, in vivo and in vitro drug efficacy testing, and operates as a subsidiary of Beijing Biocytogen Co., Ltd. Eucure Biopharma aims to improve the survival rate of tumor patients by developing effective antibody treatments.
LP Pharmaceuticals
Series B in 2017
LP Pharmaceuticals (Xiamen) Co., Ltd., located in Xiamen Biomedical Industry Base which formulates and manufactures pharmaceuticals with enhanced delivery properties. The company was founded in 2012 by a group of scientists and business professionals with extensive experience in the US and Chinese pharmaceutical industry. Proprietary delivery platforms include mucosal and oral controlled release. Therapeutic areas currently concern central nervous system, digestive system, cardiovascular, cancer and AIDS.
Douyu TV
Series D in 2017
Douyu TV is a live streaming media platform that provides live content such as games, sports, variety shows, entertainment, and more. The live-stream platform offers services like video-sharing for the students live broadcast, covers the main live game and sports as well as other live contents, enabling users to submit, view, and add commentary subtitles to videos of games, while incorporating content ranging from sports, variety shows, and entertainment. Zhang Wenming founded Douyu TV in 2013, with its headquarters in Wuhan in China.
Souche
Series E in 2017
Souche, founded by Yao Junhong in December 2012, is a prominent automotive new retail platform in China. The company has attracted significant investments, raising over $1.2 billion by August 2018 from notable organizations such as Alibaba Group and Ant Financial Services Group. Recognized in the 2017 New Global Unicorns Ranking by PitchBook, Souche aims to be a central intelligence hub for the automotive industry. Over the years, it has developed an integrated automotive retail ecosystem that includes various businesses. These encompass Tangeche, an automotive financial leasing platform; Chehang168, a B2B industrial chain service platform; Cheyipai, an online used-car trading platform; and TIHD, a car-sharing service. Additionally, Souche offers SaaS products for used-car dealers through Dafengche and operates a new-car dealership network called Maicheguanjia. The company also provides ERP systems for dealership groups and integrated supply chain logistics services. Souche is often referred to as "the Alibaba of the Chinese automotive industry."
United Imaging Healthcare
Series A in 2017
United Imaging Healthcare develops and manufactures medical equipment and solutions. Its solutions cover areas of diagnostics, radiotherapy, and healthcare information technology solutions. United Imaging Healthcare offers medical imaging products such as computed tomography, molecular imaging, magnetic resonance, and X-ray radiography products, radiotherapy equipment, and uCloud UIH Intelligent Medical Cloud, a medical cloud platform for medical resource sharing and mass diagnostic data mining. It also provides customer, technical support, dispatching, and training services. United Imaging Healthcare began operation in 2011, with its headquarters in Shanghai in China. It has locations in Concord, Cleveland, Houston, Wuhan, and Shenzhen.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.